InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Mueller John Patrick, Directeur. Officer active across 1 company, notably Entasis Therapeutics Holdings Inc.. In total, 4 disclosures have been logged. Activity tracked since 19 October 2021. The latest transaction was disclosed on 7 July 2022 (U). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
John Patrick Mueller is the Chief Development Officer at Entasis Therapeutics Holdings Inc. He plays a key role in the company's development strategy, focusing on innovation and product expansion. With extensive expertise in the pharmaceutical field, John is responsible for leading research and development efforts to enhance clinical outcomes. His commitment to scientific advancement and interdisciplinary collaboration is a significant asset for Entasis.